Treating CML & Myelofibrosis Patients

Treating CML & Myelofibrosis Patients

imedex

10 months
317 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Ellen Ritchie, M.D. assistant professor of medicine and a member of the Leukemia Program at the Weill Cornell Medical College Discusses Treating CML & Myelofibrosis Patients at Lymphoma & Myeloma on October 18, 2018.
Up Next Autoplay
Resistance/intolerance to second generation TKIs in CML: what to do next?
Resistance/intolerance to second generation TKIs in CML: what to do next?
Category: Chronic Myelogenous Leukemia
153 Views
VJHemOnc 1 year
Update on ENESTop: TFR in CML after discontinuing nilotinib
Update on ENESTop: TFR in CML after discontinuing nilotinib
Category: Chronic Myelogenous Leukemia
126 Views
VJHemOnc 1 year
Benefits of second generation TKIs for CML in the frontline
Benefits of second generation TKIs for CML in the frontline
Category: Chronic Myelogenous Leukemia
92 Views
VJHemOnc 1 year
Personalized therapy in leukemia: a case study
Personalized therapy in leukemia: a case study
Category: Chronic Myelogenous Leukemia
236 Views
VJHemOnc 1 year
New drugs for CML: are more to come?
New drugs for CML: are more to come?
Category: Chronic Myelogenous Leukemia
63 Views
VJHemOnc 1 year
Bosutinib: a new, safer TKI for frontline CML
Bosutinib: a new, safer TKI for frontline CML
Category: Chronic Myelogenous Leukemia
92 Views
VJHemOnc 1 year
Asciminib has the potential to succeed where other TKIs have failed in CML
Asciminib has the potential to succeed where other TKIs have failed in CML
Category: Chronic Myelogenous Leukemia
210 Views
VJHemOnc 1 year
DESTINY: achieving TFR by de-escalating therapy in CML
DESTINY: achieving TFR by de-escalating therapy in CML
Category: Chronic Myelogenous Leukemia
97 Views
VJHemOnc 1 year
Novel agents or imatinib for CML in the frontline setting?
Novel agents or imatinib for CML in the frontline setting?
Category: Chronic Myelogenous Leukemia
74 Views
VJHemOnc 1 year